Literature DB >> 30336691

Apnea-Hypopnea Event Duration Predicts Mortality in Men and Women in the Sleep Heart Health Study.

Matthew P Butler1,2, Jeffery T Emch3, Michael Rueschman4, Scott A Sands4,5, Steven A Shea1,6,4, Andrew Wellman4,5, Susan Redline4,5,7.   

Abstract

RATIONALE: Obstructive sleep apnea is a risk factor for mortality, but its diagnostic metric-the apnea-hypopnea index-is a poor risk predictor. The apnea-hypopnea index does not capture the range of physiological variability within and between patients, such as degree of hypoxemia and sleep fragmentation, that reflect differences in pathophysiological contributions of airway collapsibility, chemoreceptive negative feedback loop gain, and arousal threshold.
OBJECTIVES: To test whether respiratory event duration, a heritable sleep apnea trait reflective of arousal threshold, predicts all-cause mortality.
METHODS: Mortality risk as a function of event duration was estimated by Cox proportional hazards in the Sleep Heart Health Study, a prospective community-based cohort. Gender-specific hazard ratios were also calculated.
MEASUREMENTS AND MAIN RESULTS: Among 5,712 participants, 1,290 deaths occurred over 11 years of follow-up. After adjusting for demographic factors (mean age, 63 yr; 52% female), apnea-hypopnea index (mean, 13.8; SD, 15.0), smoking, and prevalent cardiometabolic disease, individuals with the shortest-duration events had a significant hazard ratio for all-cause mortality of 1.31 (95% confidence interval, 1.11-1.54). This relationship was observed in both men and women and was strongest in those with moderate sleep apnea (hazard ratio, 1.59; 95% confidence interval, 1.11-2.28).
CONCLUSIONS: Short respiratory event duration, a marker for low arousal threshold, predicts mortality in men and women. Individuals with shorter respiratory events may be predisposed to increased ventilatory instability and/or have augmented autonomic nervous system responses that increase the likelihood of adverse health outcomes, underscoring the importance of assessing physiological variation in obstructive sleep apnea.

Entities:  

Keywords:  epidemiology; mortality; obstructive sleep apnea; prospective; sleep

Mesh:

Year:  2019        PMID: 30336691      PMCID: PMC6444651          DOI: 10.1164/rccm.201804-0758OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  46 in total

1.  Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA.

Authors:  Joseph Yeboah; Susan Redline; Craig Johnson; Russell Tracy; Pamela Ouyang; Roger S Blumenthal; Gregory L Burke; David M Herrington
Journal:  Atherosclerosis       Date:  2011-08-22       Impact factor: 5.162

2.  Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study.

Authors:  Daniel J Gottlieb; Gayane Yenokyan; Anne B Newman; George T O'Connor; Naresh M Punjabi; Stuart F Quan; Susan Redline; Helaine E Resnick; Elisa K Tong; Marie Diener-West; Eyal Shahar
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

3.  Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.

Authors:  Danny J Eckert; Robert L Owens; Geoffrey B Kehlmann; Andrew Wellman; Shilpa Rahangdale; Susie Yim-Yeh; David P White; Atul Malhotra
Journal:  Clin Sci (Lond)       Date:  2011-06       Impact factor: 6.124

4.  All-cause mortality and obstructive sleep apnea severity revisited.

Authors:  Jeremy Rich; Ayelette Raviv; Nataly Raviv; Scott E Brietzke
Journal:  Otolaryngol Head Neck Surg       Date:  2012-06-11       Impact factor: 3.497

5.  Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea.

Authors:  Andrey V Zinchuk; Sangchoon Jeon; Brian B Koo; Xiting Yan; Dawn M Bravata; Li Qin; Bernardo J Selim; Kingman P Strohl; Nancy S Redeker; John Concato; Henry K Yaggi
Journal:  Thorax       Date:  2017-09-21       Impact factor: 9.139

Review 6.  Respiratory arousal from sleep: mechanisms and significance.

Authors:  R B Berry; K Gleeson
Journal:  Sleep       Date:  1997-08       Impact factor: 5.849

7.  Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas.

Authors:  Naresh M Punjabi; Anne B Newman; Terry B Young; Helaine E Resnick; Mark H Sanders
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

Review 8.  Gender differences in the clinical manifestation of obstructive sleep apnea.

Authors:  Lichuan Ye; Grace W Pien; Terri E Weaver
Journal:  Sleep Med       Date:  2009-04-28       Impact factor: 3.492

9.  Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the sleep disorders questionnaire.

Authors:  Arschang Valipour; Harald Lothaller; Helmuth Rauscher; Hartmut Zwick; Otto Chris Burghuber; Peretz Lavie
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

10.  Apnea-hypopnea index: time to wake up.

Authors:  Eyal Shahar
Journal:  Nat Sci Sleep       Date:  2014-04-05
View more
  38 in total

1.  The (Still) Elusive Definition of Hypopnea.

Authors:  Kenneth R Casey; Rachna Tiwari
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

Review 2.  Phenotypic Subtypes of OSA: A Challenge and Opportunity for Precision Medicine.

Authors:  Andrey Zinchuk; Henry K Yaggi
Journal:  Chest       Date:  2019-09-17       Impact factor: 9.410

3.  Low Prognostic Value of Novel Nocturnal Metrics in Patients With OSA and High Cardiovascular Event Risk: Post Hoc Analyses of the SAVE Study.

Authors:  Dominik Linz; Kelly A Loffler; Prashanthan Sanders; Peter Catcheside; Craig S Anderson; Danni Zheng; WeiWei Quan; Mary Barnes; Susan Redline; R Doug McEvoy; Mathias Baumert
Journal:  Chest       Date:  2020-07-14       Impact factor: 9.410

Review 4.  More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea.

Authors:  Bradley A Edwards; Susan Redline; Scott A Sands; Robert L Owens
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

5.  When will we ditch the AHI?

Authors:  Christine H J Won
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

6.  Cardiovascular and somatic comorbidities and sleep measures using three hypopnea criteria in mild obstructive sleep-disordered breathing: sex, age, and body mass index differences in a retrospective sleep clinic cohort.

Authors:  Karin Gardner Johnson; Douglas Clark Johnson; Robert Joseph Thomas; Vida Rastegar; Paul Visintainer
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

7.  Sex differences in obstructive sleep apnea phenotypes, the multi-ethnic study of atherosclerosis.

Authors:  Christine H J Won; Michelle Reid; Tamar Sofer; Ali Azarbarzin; Shaun Purcell; David White; Andrew Wellman; Scott Sands; Susan Redline
Journal:  Sleep       Date:  2020-05-12       Impact factor: 5.849

Review 8.  Reinventing polysomnography in the age of precision medicine.

Authors:  Diane C Lim; Diego R Mazzotti; Kate Sutherland; Jesse W Mindel; Jinyoung Kim; Peter A Cistulli; Ulysses J Magalang; Allan I Pack; Philip de Chazal; Thomas Penzel
Journal:  Sleep Med Rev       Date:  2020-03-20       Impact factor: 11.609

9.  The Sleep Apnea-Specific Hypoxic Burden Predicts Incident Heart Failure.

Authors:  Ali Azarbarzin; Scott A Sands; Luigi Taranto-Montemurro; Daniel Vena; Tamar Sofer; Sang-Wook Kim; Katie L Stone; David P White; Andrew Wellman; Susan Redline
Journal:  Chest       Date:  2020-04-13       Impact factor: 9.410

10.  Ganglion cell layer thickening in patients suffering from Obstructive Sleep Apnea-Hypopnea syndrome with long Mean Apnea-Hypopnea Duration during sleep.

Authors:  Evangelia Chalkiadaki; Konstantinos Andreanos; Efthymios Karmiris; Chrysoula Florou; Xanthi Tsiafaki; Anastasia Amfilochiou; Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou
Journal:  Int Ophthalmol       Date:  2020-11-17       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.